Table of Content

1 Study Coverage
1.1 Lung Disease Therapeutic Drug Product Introduction
1.2 Market by Type
1.2.1 Global Lung Disease Therapeutic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Corticosteroids
1.2.3 Bronchodilator Medications
1.2.4 Mucolytics
1.2.5 Antimicrobial Medications
1.2.6 Others
1.3 Market by Application
1.3.1 Global Lung Disease Therapeutic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lung Disease Therapeutic Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Lung Disease Therapeutic Drug Revenue by Region
2.2.1 Global Lung Disease Therapeutic Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Lung Disease Therapeutic Drug Revenue by Region (2018-2024)
2.2.3 Global Lung Disease Therapeutic Drug Revenue by Region (2024-2029)
2.2.4 Global Lung Disease Therapeutic Drug Revenue Market Share by Region (2018-2029)
2.3 Global Lung Disease Therapeutic Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Lung Disease Therapeutic Drug Sales by Region
2.4.1 Global Lung Disease Therapeutic Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Lung Disease Therapeutic Drug Sales by Region (2018-2024)
2.4.3 Global Lung Disease Therapeutic Drug Sales by Region (2024-2029)
2.4.4 Global Lung Disease Therapeutic Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Lung Disease Therapeutic Drug Sales by Manufacturers
3.1.1 Global Lung Disease Therapeutic Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Lung Disease Therapeutic Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lung Disease Therapeutic Drug in 2022
3.2 Global Lung Disease Therapeutic Drug Revenue by Manufacturers
3.2.1 Global Lung Disease Therapeutic Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Lung Disease Therapeutic Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Lung Disease Therapeutic Drug Revenue in 2022
3.3 Global Key Players of Lung Disease Therapeutic Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Lung Disease Therapeutic Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Lung Disease Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Lung Disease Therapeutic Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Lung Disease Therapeutic Drug, Product Offered and Application
3.8 Global Key Manufacturers of Lung Disease Therapeutic Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lung Disease Therapeutic Drug Sales by Type
4.1.1 Global Lung Disease Therapeutic Drug Historical Sales by Type (2018-2024)
4.1.2 Global Lung Disease Therapeutic Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Lung Disease Therapeutic Drug Sales Market Share by Type (2018-2029)
4.2 Global Lung Disease Therapeutic Drug Revenue by Type
4.2.1 Global Lung Disease Therapeutic Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Lung Disease Therapeutic Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Lung Disease Therapeutic Drug Revenue Market Share by Type (2018-2029)
4.3 Global Lung Disease Therapeutic Drug Price by Type
4.3.1 Global Lung Disease Therapeutic Drug Price by Type (2018-2024)
4.3.2 Global Lung Disease Therapeutic Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Lung Disease Therapeutic Drug Sales by Application
5.1.1 Global Lung Disease Therapeutic Drug Historical Sales by Application (2018-2024)
5.1.2 Global Lung Disease Therapeutic Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Lung Disease Therapeutic Drug Sales Market Share by Application (2018-2029)
5.2 Global Lung Disease Therapeutic Drug Revenue by Application
5.2.1 Global Lung Disease Therapeutic Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Lung Disease Therapeutic Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Lung Disease Therapeutic Drug Revenue Market Share by Application (2018-2029)
5.3 Global Lung Disease Therapeutic Drug Price by Application
5.3.1 Global Lung Disease Therapeutic Drug Price by Application (2018-2024)
5.3.2 Global Lung Disease Therapeutic Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Lung Disease Therapeutic Drug Market Size by Type
6.1.1 US & Canada Lung Disease Therapeutic Drug Sales by Type (2018-2029)
6.1.2 US & Canada Lung Disease Therapeutic Drug Revenue by Type (2018-2029)
6.2 US & Canada Lung Disease Therapeutic Drug Market Size by Application
6.2.1 US & Canada Lung Disease Therapeutic Drug Sales by Application (2018-2029)
6.2.2 US & Canada Lung Disease Therapeutic Drug Revenue by Application (2018-2029)
6.3 US & Canada Lung Disease Therapeutic Drug Market Size by Country
6.3.1 US & Canada Lung Disease Therapeutic Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Lung Disease Therapeutic Drug Sales by Country (2018-2029)
6.3.3 US & Canada Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Lung Disease Therapeutic Drug Market Size by Type
7.1.1 Europe Lung Disease Therapeutic Drug Sales by Type (2018-2029)
7.1.2 Europe Lung Disease Therapeutic Drug Revenue by Type (2018-2029)
7.2 Europe Lung Disease Therapeutic Drug Market Size by Application
7.2.1 Europe Lung Disease Therapeutic Drug Sales by Application (2018-2029)
7.2.2 Europe Lung Disease Therapeutic Drug Revenue by Application (2018-2029)
7.3 Europe Lung Disease Therapeutic Drug Market Size by Country
7.3.1 Europe Lung Disease Therapeutic Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Lung Disease Therapeutic Drug Sales by Country (2018-2029)
7.3.3 Europe Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Lung Disease Therapeutic Drug Market Size
8.1.1 China Lung Disease Therapeutic Drug Sales (2018-2029)
8.1.2 China Lung Disease Therapeutic Drug Revenue (2018-2029)
8.2 China Lung Disease Therapeutic Drug Market Size by Application
8.2.1 China Lung Disease Therapeutic Drug Sales by Application (2018-2029)
8.2.2 China Lung Disease Therapeutic Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Lung Disease Therapeutic Drug Market Size by Type
9.1.1 Asia Lung Disease Therapeutic Drug Sales by Type (2018-2029)
9.1.2 Asia Lung Disease Therapeutic Drug Revenue by Type (2018-2029)
9.2 Asia Lung Disease Therapeutic Drug Market Size by Application
9.2.1 Asia Lung Disease Therapeutic Drug Sales by Application (2018-2029)
9.2.2 Asia Lung Disease Therapeutic Drug Revenue by Application (2018-2029)
9.3 Asia Lung Disease Therapeutic Drug Sales by Region
9.3.1 Asia Lung Disease Therapeutic Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Lung Disease Therapeutic Drug Revenue by Region (2018-2029)
9.3.3 Asia Lung Disease Therapeutic Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Lung Disease Therapeutic Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Lung Disease Therapeutic Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GSK Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AstraZeneca Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Boehringer Ingelheim Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novartis Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Overview
11.5.3 Mylan Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Mylan Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Recent Developments
11.6 Vertex Pharmaceuticals
11.6.1 Vertex Pharmaceuticals Company Information
11.6.2 Vertex Pharmaceuticals Overview
11.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Vertex Pharmaceuticals Recent Developments
11.7 F. Hoffman La Roche
11.7.1 F. Hoffman La Roche Company Information
11.7.2 F. Hoffman La Roche Overview
11.7.3 F. Hoffman La Roche Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 F. Hoffman La Roche Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 F. Hoffman La Roche Recent Developments
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Information
11.8.2 Teva Pharmaceuticals Overview
11.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Teva Pharmaceuticals Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceuticals Recent Developments
11.9 Cipla
11.9.1 Cipla Company Information
11.9.2 Cipla Overview
11.9.3 Cipla Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Cipla Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cipla Recent Developments
11.10 Fibrogen
11.10.1 Fibrogen Company Information
11.10.2 Fibrogen Overview
11.10.3 Fibrogen Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Fibrogen Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Fibrogen Recent Developments
11.11 Liminal Biosciences
11.11.1 Liminal Biosciences Company Information
11.11.2 Liminal Biosciences Overview
11.11.3 Liminal Biosciences Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Liminal Biosciences Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Liminal Biosciences Recent Developments
11.12 PharmAkea Therapeutics
11.12.1 PharmAkea Therapeutics Company Information
11.12.2 PharmAkea Therapeutics Overview
11.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 PharmAkea Therapeutics Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 PharmAkea Therapeutics Recent Developments
11.13 IQVIA
11.13.1 IQVIA Company Information
11.13.2 IQVIA Overview
11.13.3 IQVIA Lung Disease Therapeutic Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 IQVIA Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 IQVIA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lung Disease Therapeutic Drug Industry Chain Analysis
12.2 Lung Disease Therapeutic Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lung Disease Therapeutic Drug Production Mode & Process
12.4 Lung Disease Therapeutic Drug Sales and Marketing
12.4.1 Lung Disease Therapeutic Drug Sales Channels
12.4.2 Lung Disease Therapeutic Drug Distributors
12.5 Lung Disease Therapeutic Drug Customers
13 Market Dynamics
13.1 Lung Disease Therapeutic Drug Industry Trends
13.2 Lung Disease Therapeutic Drug Market Drivers
13.3 Lung Disease Therapeutic Drug Market Challenges
13.4 Lung Disease Therapeutic Drug Market Restraints
14 Key Findings in The Global Lung Disease Therapeutic Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Lung Disease Therapeutic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Corticosteroids
Table 3. Major Manufacturers of Bronchodilator Medications
Table 4. Major Manufacturers of Mucolytics
Table 5. Major Manufacturers of Antimicrobial Medications
Table 6. Major Manufacturers of Others
Table 7. Global Lung Disease Therapeutic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Lung Disease Therapeutic Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Lung Disease Therapeutic Drug Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Lung Disease Therapeutic Drug Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Lung Disease Therapeutic Drug Revenue Market Share by Region (2018-2024)
Table 12. Global Lung Disease Therapeutic Drug Revenue Market Share by Region (2024-2029)
Table 13. Global Lung Disease Therapeutic Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Lung Disease Therapeutic Drug Sales by Region (2018-2024) & (K Units)
Table 15. Global Lung Disease Therapeutic Drug Sales by Region (2024-2029) & (K Units)
Table 16. Global Lung Disease Therapeutic Drug Sales Market Share by Region (2018-2024)
Table 17. Global Lung Disease Therapeutic Drug Sales Market Share by Region (2024-2029)
Table 18. Global Lung Disease Therapeutic Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Lung Disease Therapeutic Drug Sales Share by Manufacturers (2018-2024)
Table 20. Global Lung Disease Therapeutic Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Lung Disease Therapeutic Drug Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Lung Disease Therapeutic Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Lung Disease Therapeutic Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Lung Disease Therapeutic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Lung Disease Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutic Drug as of 2022)
Table 26. Global Key Manufacturers of Lung Disease Therapeutic Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Lung Disease Therapeutic Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Lung Disease Therapeutic Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (K Units)
Table 31. Global Lung Disease Therapeutic Drug Sales by Type (2024-2029) & (K Units)
Table 32. Global Lung Disease Therapeutic Drug Sales Share by Type (2018-2024)
Table 33. Global Lung Disease Therapeutic Drug Sales Share by Type (2024-2029)
Table 34. Global Lung Disease Therapeutic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Lung Disease Therapeutic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Lung Disease Therapeutic Drug Revenue Share by Type (2018-2024)
Table 37. Global Lung Disease Therapeutic Drug Revenue Share by Type (2024-2029)
Table 38. Lung Disease Therapeutic Drug Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Lung Disease Therapeutic Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (K Units)
Table 41. Global Lung Disease Therapeutic Drug Sales by Application (2024-2029) & (K Units)
Table 42. Global Lung Disease Therapeutic Drug Sales Share by Application (2018-2024)
Table 43. Global Lung Disease Therapeutic Drug Sales Share by Application (2024-2029)
Table 44. Global Lung Disease Therapeutic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Lung Disease Therapeutic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Lung Disease Therapeutic Drug Revenue Share by Application (2018-2024)
Table 47. Global Lung Disease Therapeutic Drug Revenue Share by Application (2024-2029)
Table 48. Lung Disease Therapeutic Drug Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Lung Disease Therapeutic Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Lung Disease Therapeutic Drug Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Lung Disease Therapeutic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Lung Disease Therapeutic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Lung Disease Therapeutic Drug Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Lung Disease Therapeutic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Lung Disease Therapeutic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Lung Disease Therapeutic Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Lung Disease Therapeutic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Lung Disease Therapeutic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 63. Europe Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (K Units)
Table 64. Europe Lung Disease Therapeutic Drug Sales by Type (2024-2029) & (K Units)
Table 65. Europe Lung Disease Therapeutic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Lung Disease Therapeutic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (K Units)
Table 68. Europe Lung Disease Therapeutic Drug Sales by Application (2024-2029) & (K Units)
Table 69. Europe Lung Disease Therapeutic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Lung Disease Therapeutic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Lung Disease Therapeutic Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Lung Disease Therapeutic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Lung Disease Therapeutic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 75. Europe Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 76. China Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (K Units)
Table 77. China Lung Disease Therapeutic Drug Sales by Type (2024-2029) & (K Units)
Table 78. China Lung Disease Therapeutic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Lung Disease Therapeutic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (K Units)
Table 81. China Lung Disease Therapeutic Drug Sales by Application (2024-2029) & (K Units)
Table 82. China Lung Disease Therapeutic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Lung Disease Therapeutic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (K Units)
Table 85. Asia Lung Disease Therapeutic Drug Sales by Type (2024-2029) & (K Units)
Table 86. Asia Lung Disease Therapeutic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Lung Disease Therapeutic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (K Units)
Table 89. Asia Lung Disease Therapeutic Drug Sales by Application (2024-2029) & (K Units)
Table 90. Asia Lung Disease Therapeutic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Lung Disease Therapeutic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Lung Disease Therapeutic Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Lung Disease Therapeutic Drug Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Lung Disease Therapeutic Drug Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Lung Disease Therapeutic Drug Sales by Region (2018-2024) & (K Units)
Table 96. Asia Lung Disease Therapeutic Drug Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 110. GSK Company Information
Table 111. GSK Description and Major Businesses
Table 112. GSK Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. GSK Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. GSK Recent Developments
Table 115. AstraZeneca Company Information
Table 116. AstraZeneca Description and Major Businesses
Table 117. AstraZeneca Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. AstraZeneca Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. AstraZeneca Recent Developments
Table 120. Boehringer Ingelheim Company Information
Table 121. Boehringer Ingelheim Description and Major Businesses
Table 122. Boehringer Ingelheim Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Boehringer Ingelheim Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Boehringer Ingelheim Recent Developments
Table 125. Novartis Company Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Novartis Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novartis Recent Developments
Table 130. Mylan Company Information
Table 131. Mylan Description and Major Businesses
Table 132. Mylan Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Mylan Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Mylan Recent Developments
Table 135. Vertex Pharmaceuticals Company Information
Table 136. Vertex Pharmaceuticals Description and Major Businesses
Table 137. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Vertex Pharmaceuticals Recent Developments
Table 140. F. Hoffman La Roche Company Information
Table 141. F. Hoffman La Roche Description and Major Businesses
Table 142. F. Hoffman La Roche Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. F. Hoffman La Roche Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. F. Hoffman La Roche Recent Developments
Table 145. Teva Pharmaceuticals Company Information
Table 146. Teva Pharmaceuticals Description and Major Businesses
Table 147. Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Teva Pharmaceuticals Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Teva Pharmaceuticals Recent Developments
Table 150. Cipla Company Information
Table 151. Cipla Description and Major Businesses
Table 152. Cipla Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Cipla Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Cipla Recent Developments
Table 155. Fibrogen Company Information
Table 156. Fibrogen Description and Major Businesses
Table 157. Fibrogen Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Fibrogen Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Fibrogen Recent Developments
Table 160. Liminal Biosciences Company Information
Table 161. Liminal Biosciences Description and Major Businesses
Table 162. Liminal Biosciences Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Liminal Biosciences Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Liminal Biosciences Recent Developments
Table 165. PharmAkea Therapeutics Company Information
Table 166. PharmAkea Therapeutics Description and Major Businesses
Table 167. PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. PharmAkea Therapeutics Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. PharmAkea Therapeutics Recent Developments
Table 170. IQVIA Company Information
Table 171. IQVIA Description and Major Businesses
Table 172. IQVIA Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. IQVIA Lung Disease Therapeutic Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. IQVIA Recent Developments
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Lung Disease Therapeutic Drug Distributors List
Table 178. Lung Disease Therapeutic Drug Customers List
Table 179. Lung Disease Therapeutic Drug Market Trends
Table 180. Lung Disease Therapeutic Drug Market Drivers
Table 181. Lung Disease Therapeutic Drug Market Challenges
Table 182. Lung Disease Therapeutic Drug Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Lung Disease Therapeutic Drug Product Picture
Figure 2. Global Lung Disease Therapeutic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Lung Disease Therapeutic Drug Market Share by Type in 2022 & 2029
Figure 4. Corticosteroids Product Picture
Figure 5. Bronchodilator Medications Product Picture
Figure 6. Mucolytics Product Picture
Figure 7. Antimicrobial Medications Product Picture
Figure 8. Others Product Picture
Figure 9. Global Lung Disease Therapeutic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Lung Disease Therapeutic Drug Market Share by Application in 2022 & 2029
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Lung Disease Therapeutic Drug Report Years Considered
Figure 15. Global Lung Disease Therapeutic Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Lung Disease Therapeutic Drug Revenue 2018-2029 (US$ Million)
Figure 17. Global Lung Disease Therapeutic Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Lung Disease Therapeutic Drug Revenue Market Share by Region (2018-2029)
Figure 19. Global Lung Disease Therapeutic Drug Sales 2018-2029 ((K Units)
Figure 20. Global Lung Disease Therapeutic Drug Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Lung Disease Therapeutic Drug Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Lung Disease Therapeutic Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Lung Disease Therapeutic Drug Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Lung Disease Therapeutic Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Lung Disease Therapeutic Drug Sales YoY (2018-2029) & (K Units)
Figure 26. China Lung Disease Therapeutic Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Lung Disease Therapeutic Drug Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Lung Disease Therapeutic Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Lung Disease Therapeutic Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Lung Disease Therapeutic Drug in the World: Market Share by Lung Disease Therapeutic Drug Revenue in 2022
Figure 33. Global Lung Disease Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Lung Disease Therapeutic Drug Sales Market Share by Type (2018-2029)
Figure 35. Global Lung Disease Therapeutic Drug Revenue Market Share by Type (2018-2029)
Figure 36. Global Lung Disease Therapeutic Drug Sales Market Share by Application (2018-2029)
Figure 37. Global Lung Disease Therapeutic Drug Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Lung Disease Therapeutic Drug Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Lung Disease Therapeutic Drug Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Lung Disease Therapeutic Drug Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Lung Disease Therapeutic Drug Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Lung Disease Therapeutic Drug Revenue Share by Country (2018-2029)
Figure 43. US & Canada Lung Disease Therapeutic Drug Sales Share by Country (2018-2029)
Figure 44. U.S. Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Lung Disease Therapeutic Drug Sales Market Share by Type (2018-2029)
Figure 47. Europe Lung Disease Therapeutic Drug Revenue Market Share by Type (2018-2029)
Figure 48. Europe Lung Disease Therapeutic Drug Sales Market Share by Application (2018-2029)
Figure 49. Europe Lung Disease Therapeutic Drug Revenue Market Share by Application (2018-2029)
Figure 50. Europe Lung Disease Therapeutic Drug Revenue Share by Country (2018-2029)
Figure 51. Europe Lung Disease Therapeutic Drug Sales Share by Country (2018-2029)
Figure 52. Germany Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 53. France Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 57. China Lung Disease Therapeutic Drug Sales Market Share by Type (2018-2029)
Figure 58. China Lung Disease Therapeutic Drug Revenue Market Share by Type (2018-2029)
Figure 59. China Lung Disease Therapeutic Drug Sales Market Share by Application (2018-2029)
Figure 60. China Lung Disease Therapeutic Drug Revenue Market Share by Application (2018-2029)
Figure 61. Asia Lung Disease Therapeutic Drug Sales Market Share by Type (2018-2029)
Figure 62. Asia Lung Disease Therapeutic Drug Revenue Market Share by Type (2018-2029)
Figure 63. Asia Lung Disease Therapeutic Drug Sales Market Share by Application (2018-2029)
Figure 64. Asia Lung Disease Therapeutic Drug Revenue Market Share by Application (2018-2029)
Figure 65. Asia Lung Disease Therapeutic Drug Revenue Share by Region (2018-2029)
Figure 66. Asia Lung Disease Therapeutic Drug Sales Share by Region (2018-2029)
Figure 67. Japan Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 71. India Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Lung Disease Therapeutic Drug Sales Share by Country (2018-2029)
Figure 78. Brazil Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Lung Disease Therapeutic Drug Revenue (2018-2029) & (US$ Million)
Figure 83. Lung Disease Therapeutic Drug Value Chain
Figure 84. Lung Disease Therapeutic Drug Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed